Deranged liver among Sudanese patients with dengue virus infection in Port Sudan Teaching Hospital

Bashir  Abdrhman Bashir Mohammed

doi:10.52981/sjms.v12i3.1438

Bashir Abdrhman Bashir Mohammed Assistant Professor of Hematology, Chairman of Hematology Department, Medical Laboratory Sciences Division, Port Sudan Ahlia College, Port Sudan, Sudan

DOI: https://doi.org/10.52981/sjms.v12i3.1438

Keywords: Deranged liver, Dengue, DHF, Coagulation factors, Sudan

Abstract

Background: Deranged liver is a well-recognized feature of dengue infection, often demonstrated by coagulopathy and mild to moderate increase in transaminase levels although jaundice and fulminant hepatic failure are generally uncommon.

Objective: This study aimed to evaluate the hepatic effect of dengue fever amongst Sudanese patients.

Materials and Methods: A cross-sectional descriptive study recruited in Port Sudan teaching hospital in the period from February 2013 to June 2014. 334 cases of dengue along with 101 cases of control were enrolled. The rapid immune chromatographies test was used to confirm positive dengue cases and WHO criteria were used for classifying the dengue severity. Prothrombin time (PT), partial thromboplastin time (PTT), fibrinogen level (FB), platelet count (PLT), aspartate aminotransferase (AST), alanine aminotransferase (ALT) and C-reactive protein (CRP) were all measured.

Results: PT, PTT, and FB were found to be significantly higher in the infected cohort when compared to the controls (P < 0.0001). PT was prolonged in 9%, PTT was prolonged in 12.6% and shortened by 5.4% of the patients, whereas hypofibrinogenemia in 18.3% and hyperfibrinogenemia in 67.4% of the patients. Bleeding was seen in 10.5% of patients and thrombocytopenia was detected in 83.5% of patients. Out of 334 patients, 101 (30.2%) had abnormal coagulation results. Of 101 patients, 72 were subjected mixing studies for PT and PTT that revealed deficiencies in factors VIII (35%), IX (10%), V (10%), X (19%), and XII (14%). 43.6% patients had elevated AST and 21.8% had elevated ALT.

Conclusion: This study demonstrated that hepatic dysfunction may be attributed to dengue virus infection which evident by prolongation in PT and PTT as well as hypofibrinogenemia and factor deficiencies.

References

[1] M. G. Guzmán and G. Kouri, “Dengue: an update,” The Lancet Infectious Diseases, vol. 2, no. 1, pp. 33–42, 2002.
[2] C. A. Laughlin, D. M. Morens, M. C. Cassetti et al., “Dengue research opportunities in the Americas,” Journal of Infectious Diseases, vol. 206, no. 7, pp. 1121–1127, 2012.
[3] A. Malik, K. Earhart, E. Mohareb et al., “Dengue hemorrhagic fever outbreak in children in Port Sudan,” Journal of Infection and Public Health, vol. 4, no. 1, pp. 1–6, 2011.
[4] KA. Ali and S. Abu elgasim, “A correlation study between clinical manifestation of dengue fever and degree of liver injury,” J Microbiol Antimicrob, vol. 4, no. 2, pp. 45–48, 2012.
[5] Y.-C. Chuang, Y.-S. Lin, H.-S. Liu, J.-R. Wang, and T.-M. Yeh, “Antibodies against thrombin in dengue patients contain both anti-thrombotic and pro-fibrinolytic activities,” Thrombosis and Haemostasis, vol. 110, no. 2, pp. 358–365, 2013.
[6] M. S. Mustafa, V. Rasotgi, S. Jain, and V. Gupta, “Discovery of fifth serotype of dengue virus (DENV-5): a new public health dilemma in dengue control,” Medical Journal Armed Forces India, vol. 71, no. 1, pp. 67–70, 2015.
[7] S. L. Seneviratne, G. N. Malavige, and H. J. de Silva, “Pathogenesis of Liver involvement during dengue viral infections,” Trans R Soc Trop Med Hyg, vol. 100, pp. 608–614, 2007.
[8] L. C. Lum, S. K. Lam, R. George, and S. Devi, “Fulminant hepatitis in dengue infection,” The Southeast Asian journal of tropical medicine and public health, vol. 24, no. 3, pp. 467–471, 1993.
[9] R. S. Chhina, O. Goyal, D. K. Chhina, P. Goyal, R. Kumarb, and S. Puric, “Liver function tests in patients with dengue viral infection,” Dengue Bulletin, vol. 32, pp. 110–117, 2008.
[10] A. Goal et al., “Dengue fever- A Dangerous Foe,” JIACM, pp. 247–258, 2004.
[11] K. Jagadishkumar, P. Jain, V. G. Manjunath, and L. Umesh, “Hepatic involvement in dengue fever in children,” Iranian Journal of Pediatrics, vol. 22, no. 2, pp. 231–236,2012.
[12] D. T. Trung, L. T. T. Thao, T. T. Hien et al., “Liver involvement associated with dengue infection in adults in Vietnam,” American Journal of Tropical Medicine and Hygiene, vol. 83, no. 4, pp. 774–780, 2010.
[13] S. Itha, R. Kashyap, N. Krishnani, V. A. Saraswat, G. Choudhuri, R. Aggarwal et al., “Profile of liver involvement in dengue virus infection,” National Medical Journal of India, vol. 18, no. 3, pp. 127–130, 2005.
[14] M. Wong and E. Shen, “The Utility of liver function tests in Dengue,” Ann Acad Med Singapore, vol. 37, p. 82, 2008.
[15] V. Shukla and A. Chandra, “A study of Hepatic Dysfunction in Dengue,” J Assoc Physicians India, vol. 61, no. 7, pp. 450–451, 2013.
[16] M. M. A. Faridi, A. Aggarwal, M. Kumar, and A. Sarafrazul, “Clinical and biochemical profile of dengue haemorrhagic fever in children in Delhi,” Tropical Doctor, vol. 38, no. 1, pp. 28–30, 2008.
[17] W. Petdachai, “Hepatic dysfunction in children with dengue shock syndrome,” Dengue Bulletin, vol. 29, pp. 112–118, 2005.
[18] S. L. Seneviratne, G. N. Malavige, and H. J. de Silva, “Pathogenesis of liver involvement during dengue viral infections,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 100, no. 7, pp. 608–614, 2006.
[19] L. J. Souza, J. G. Alves, R. M. Nogueira et al., “Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1, 585 cases,” Braz J Infect Dis, vol. 8, no. 2, pp. 156–63, 2004.
[20] M. Wong and E. Shen, “The Utility of liver function tests in Dengue,” Ann Acad Med, vol. 37, no. 1, p. 82, 2008.
[21] R.Karoli,J.Fatima,Z.Siddiqi,K.I.Kazmi,andA.R.Sultania,“Clinicalprofileofdengue infection at a teaching hospital in North India,” The Journal of Infection in Developing Countries, vol. 6, no. 07, 2012.
[22] T.-S. Ho, S.-M. Wang, Y.-S. Lin, and C.-C. Liu, “Clinical and laboratory predictive markers for acute dengue infection,” Journal of Biomedical Science, vol. 20, no. 1, article 75, 2013.
[23] M. Juffrie, G. M. Vo Meer, C. E. Hack et al., “Inflammatory mediators in dengue virus infection in children: Interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2,” American Journal of Tropical Medicine and Hygiene, vol. 65, no. 1, pp. 70–75, 2001.
[24] S. Kutsuna, K. Hayakawa, Y. Kato et al., “The usefulness of serum C-reactive protein and total bilirubin levels for distinguishing between dengue fever and malaria in returned travelers,” American Journal of Tropical Medicine and Hygiene, vol. 90, no. 3, pp. 444–448, 2014.